Sartorius Stedim Biotech Investor Relations Service

Nine-Months Results 2014

Investor Relations News: January to September 2014 (182 KB)

Joachim Kreuzburg, CEO and Chairman of the Board of the Sartorius Stedim Biotech Group, has discussed the nine-month figures for 2014 on October 21, at 3.30 p.m. CET.

Download Presentation on Nine-Months Results 2014 (1.1 MB)

Download Webcast (10.8 MB)

News

Nine-Month Figures for 2014: Sartorius Stedim Biotech Continues on the Growth Track

in € million unless otherwise specified9 months 20149 months 2013Growth in %Growth in %const. fx Order intake509.7453.112.513.4Sales revenue494.3436.613.214.1  ...[more]

Date: 21.10.2014     Category: Sartorius Stedim Biotech

Miriam Monge to Join Sartorius Stedim Biotech as Director

Aubagne, August 26, 2014 – Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, today announced the appointment of Miriam Monge as Director of Marketing for SSB’s...[more]

Date: 26.08.2014     Category: Sartorius Stedim Biotech

Sartorius Stedim Biotech Share (DIM)

Petra Kirchhoff

Vice President of Corporate Communications & Investor Relations

petra.kirchhoff
(at)sartorius.com
Phone: +49 551 308-1686

Andreas Theisen

Director Investor Relations

andreas.theisen
(at)sartorius.com

Phone: +49 551 308-1668